COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth.
ERJ Open Res
; 6(4)2020 Oct.
Article
in English
| MEDLINE | ID: covidwho-951520
ABSTRACT
Experience with very mild #COVID19 disease courses in two severe eosinophilic asthmatics with complete eosinophil depletion due to benralizumab treatment counters the recent theories that eosinophilia is protective in COVID-19 infections https//bit.ly/3cnEFvg.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
23120541.00457-2020
Similar
MEDLINE
...
LILACS
LIS